Agape ATP Corporation

Equities

ATPC

US0083891087

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Other stock markets 19:29:02 28/05/2024 BST			5-day change	1st Jan Change
0.2681 ^USD	-3.60%		+4.32%	-58.04%

05-14	Agape ATP Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-11	Certain Common Stock of Agape ATP Corporation are subject to a Lock-Up Agreement Ending on 11-APR-2024.	CI

Agape ATP Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022

November 14, 2022 at 11:06 am

Agape ATP Corporation reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.663889 million compared to USD 0.201284 million a year ago. Net loss was USD 0.240712 million compared to USD 0.571265 million a year ago.
For the nine months, sales was USD 1.47 million compared to USD 0.80685 million a year ago. Net loss was USD 0.954711 million compared to USD 1.55 million a year ago. Basic loss per share from continuing operations was USD 0.01.

Latest news about Agape ATP Corporation

Agape ATP Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Certain Common Stock of Agape ATP Corporation are subject to a Lock-Up Agreement Ending on 11-APR-2024.	04-10	CI
Agape ATP Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
Top Premarket Gainers	01-30	MT
Agape ATP Corporation Elects Wilfrendo Fernando Cortizo as Director	11-27	CI
Sector Update: Health Care Stocks Advance Late Afternoon	11-22	MT
Top MIdday Gainers	11-22	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	11-22	MT
Sector Update: Health Care	11-22	MT
Agape ATP's Shares Rise After Board Approves $1 Million Stock Buyback Plan	11-22	MT
Agape ATP's Board Approves $1 Million Stock Buyback Plan	11-22	MT
Agape ATP Corporation announces an Equity Buyback for $1 million worth of its shares.	11-22	CI
Agape ATP Corporation authorizes a Buyback Plan.	11-16	CI
Agape ATP Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Agape ATP Corporation signed an memorandum of agreement to acquire a 51% stake in Volt Industries Sdn. Bhd.	11-06	CI
Agape Closes $6.6 Million Public Offering	13/10/23	MT
Agape ATP Corporation(NasdaqCM:ATPC) added to NASDAQ Composite Index	12/10/23	CI
Agape ATP Corporation has completed an IPO in the amount of $6.6 million.	10/10/23	CI
Agape ATP Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Agape ATP Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Agape ATP Corporation Announces Executive Changes	04/04/23	CI
Agape ATP Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23	CI
Agape ATP Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
Agape ATP Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22	CI
Agape ATP Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22	CI

Chart Agape ATP Corporation

Duration

Period

More charts

Company Profile

Agape ATP Corporation is a Malaysia-based investment holding company. The Company provides health and wellness products and advisory services in the Malaysian market. The Company offers three series of products: ATP Zeta Health Program, ENERGETIQUE and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to promote health and general wellbeing, as well as to prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. It ENERGETIQUE product series is comprised of ENERGETIQUE Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser. Its BEAUNIQUE product series focuses on the research of its dietâs impact on modifying gene expressions in order to address genetic variations and deliver a personalized nutrigenomic solution for every individual.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
AGAPE ATP CORPORATION	-58.04%	21.4M
ABBOTT LABORATORIES	-7.62%	181B
MEDTRONIC PLC	-0.49%	108B
BECTON, DICKINSON AND COMPANY	-7.10%	66.12B
DEXCOM, INC.	+2.91%	50.65B
CENCORA, INC.	+5.34%	43.11B
HOYA CORPORATION	+3.49%	40.74B
METTLER-TOLEDO INTERNATIONAL, INC.	+19.59%	31.6B
TERUMO CORPORATION	+16.38%	25.56B
WEST PHARMACEUTICAL SERVICES, INC.	-6.84%	24.16B

Other Medical Equipment, Supplies & Distribution